RESUMEN
The present study describes the identification of highly potent dimeric 1,2,4-benzothiadiazine 1,1-dioxide (BTD)-type positive allosteric modulators of the AMPA receptors (AMPApams) obtained by linking two monomeric BTD scaffolds through their respective 6-positions. Using previous X-ray data from monomeric BTDs cocrystallized with the GluA2 ligand-binding domain (LBD), a molecular modeling approach was performed to predict the preferred dimeric combinations. Two 6,6-ethylene-linked dimeric BTD compounds (16 and 22) were prepared and evaluated as AMPApams on HEK293 cells expressing GluA2o( Q) (calcium flux experiment). These compounds were found to be about 10,000 times more potent than their respective monomers, the most active dimeric compound being the bis-4-cyclopropyl-substituted compound 22 [6,6'-(ethane-1,2-diyl)bis(4-cyclopropyl-3,4-dihydro-2 H-1,2,4-benzothiadiazine 1,1-dioxide], with an EC50 value of 1.4 nM. As a proof of concept, the bis-4-methyl-substituted dimeric compound 16 (EC50 = 13 nM) was successfully cocrystallized with the GluA2o-LBD and was found to occupy the two BTD binding sites at the LBD dimer interface.
Asunto(s)
Regulación Alostérica/efectos de los fármacos , Receptores AMPA/química , Receptores AMPA/metabolismo , Benzotiadiazinas/química , Sitios de Unión , Técnicas de Química Sintética , Cristalografía por Rayos X , Dimerización , Diseño de Fármacos , Evaluación Preclínica de Medicamentos/métodos , Células HEK293 , Humanos , Simulación del Acoplamiento Molecular , Dominios ProteicosRESUMEN
The utility of green silver nanoparticles (AgNPs) in veterinary medicine is steadily increasing as they have many therapeutic applications against pathogens and arthropods of livestock. In this study, green AgNPs using neem (N-AgNPs), 2,3-dehydrosalanol (2,3-DHS-AgNPs) and quercetin dihydrate (QDH-AgNPs) were synthesised and characterised. Synthesised compounds were characterised by UV-Vis spectroscopy and the peak absorbance was recorded at 370 nm for neem extract. For N-AgNPs, 2,3-DHS-AgNPs and QDH-AgNPs, the maximum absorbance peaks were at 430, 230 and 220 nm, respectively. The FTIR analysis confirmed the synthesis of green AgNPs. The XRD pattern of N-AgNPs showed the peaks corresponding to whole spectra of 2 θ values ranging from 10-80. The relatively higher intensity of (111, 222) planes in face centred cubic crystalline structure supports the formation of synthesised AgNPs. In DLS analysis, the hydrodynamic diameter of neem leaf extract was found to be 259.8 nm, followed by 5.3, 6.7 and 261.8 nm for 2,3-DHS-AgNPs, N-AgNPs and QDH-AgNPs, respectively. Based on the transmission electron microscopy and scanning electron microscopy image analyses, confirmed the formation of N-AgNPs, 2,3-DHS-AgNPs and QDH-AgNPs. These eco-friendly phyto-AgNPs may be of use as an effective alternative to chemical control methods against the arthropods of livestock.
Asunto(s)
Acaricidas/administración & dosificación , Azadirachta/química , Benzotiadiazinas/administración & dosificación , Nanopartículas del Metal/administración & dosificación , Quercetina/administración & dosificación , Plata/administración & dosificación , Acaricidas/química , Benzotiadiazinas/química , Tecnología Química Verde/métodos , Ensayo de Materiales , Nanopartículas del Metal/química , Nanopartículas del Metal/ultraestructura , Tamaño de la Partícula , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Hojas de la Planta/química , Quercetina/química , Resultado del TratamientoRESUMEN
A "heart-cut" two-dimensional achiral-chiral liquid chromatography triple-quadrupole mass spectrometry method (LC-LC-MS/MS) was developed and coupled to in vivo cerebral microdialysis to evaluate the brain response to the chiral compound (±)-7-chloro-5-(3-furanyl)-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide ((±)-1), a potent positive allosteric modulator (PAM) of AMPA receptor. The method was successfully employed to evaluate also its stereoselective metabolism and in vitro biological activity. In particular, the LC achiral method developed, employs a pentafluorinated silica based column (Discovery HS-F5) to separate dopamine, acetylcholine, serotonin, (±)-1 and its two hepatic metabolites. In the "heart-cut" two-dimension achiral-chiral configuration, (±)-1 and (±)-1-d4 eluted from the achiral column (1st dimension), were transferred to a polysaccharide-based chiral column (2nd dimension, Chiralcel OD-RH) by using an automatic six-port valve. Single enantiomers of (±)-1 were separated and detected using electrospray positive ionization mode and quantified in selected reaction monitoring mode. The method was validated and showed good performance in terms of linearity, accuracy and precision. The new method employed showed several possible applications in the evaluation of: (a) brain response to neuroactive compounds by measuring variations in the brain extracellular levels of selected neurotransmitters and other biomarkers; (b) blood brain barrier penetration of drug candidates by measuring the free concentration of the drug in selected brain areas; (c) the presence of drug metabolites in the brain extracellular fluid that could prove very useful during drug discovery; (d) a possible stereoselective metabolization or blood brain barrier stereoselective crossing of chiral drugs. Finally, compared to the methods reported in the literature, this technique avoids the necessity of euthanizing an animal at each time point to measure drug concentration in whole brain tissue and provides continuous monitoring of extracellular concentrations of single chiral drug enantiomers along with its metabolites in specific brain regions at each selected time point for a desired period by using a single animal.
Asunto(s)
Benzotiadiazinas/farmacología , Encéfalo/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Cromatografía Liquida , Evaluación Preclínica de Medicamentos/métodos , Microdiálisis , Espectrometría de Masas en Tándem , Acetilcolina/química , Animales , Encéfalo/metabolismo , Cromatografía Líquida de Alta Presión , Sistemas de Liberación de Medicamentos , Masculino , Ratones , Ratones Endogámicos C57BL , Reproducibilidad de los Resultados , EstereoisomerismoRESUMEN
In order to investigate aerobic degradation potential for the herbicides bentazone, mecoprop and dichlorprop, anaerobic groundwater samples from two monitoring and three drinking water wells near a drinking water abstraction field in Nybølle, Denmark, were screened for their degradation potential for the herbicides. In the presence of oxygen (14)C-labelled bentazone and mecoprop were removed significantly from the two monitoring wells' groundwater samples. Oxygen was added to microcosms in order to investigate whether different oxygen concentrations stimulate the biodegradation of the three herbicides in microcosms using groundwater and sandy aquifer materials. To maintain a certain oxygen concentration this level was measured from the outside of the bottles with a fibre oxygen meter using oxygen-sensitive luminescent sensor foil mounted inside the microcosm, to which supplementary oxygen was added. The highest oxygen concentrations (corresponding to 4-11 mg L(-1)) stimulated degradation (a 14-27% increase for mecoprop, 3-9% for dichlorprop and 15-20% for bentazone) over an experimental period of 200 days. Oxygen was required to biodegrade the herbicides, since no degradation was observed under anaerobic conditions. This is the first time bentazone degradation has been observed in aquifer material at low oxygen concentrations (2 mg L(-1)). The sediment had substantial oxygen consumption (0.92-1.45O2 g(-1)dw over 200 days) and oxygen was depleted rapidly in most incubations soon after its addition, which might be due to the oxidation of organic matter and other reduced species such as Fe(2+), S(2-) and Mn in sediment before the biodegradation of herbicides takes place. This study suggests that oxygen enhancement around a drinking water abstraction field could stimulate the bioremediation of diffuse source contamination.
Asunto(s)
Sedimentos Geológicos/química , Agua Subterránea/química , Herbicidas/metabolismo , Ácido 2,4-Diclorofenoxiacético/análogos & derivados , Ácido 2,4-Diclorofenoxiacético/metabolismo , Ácido 2-Metil-4-clorofenoxiacético/análogos & derivados , Ácido 2-Metil-4-clorofenoxiacético/metabolismo , Aerobiosis , Benzotiadiazinas/metabolismo , Biodegradación Ambiental , Dinamarca , Restauración y Remediación Ambiental/métodos , Sedimentos Geológicos/microbiología , Agua Subterránea/microbiología , Oxígeno/metabolismo , Contaminantes Químicos del Agua/metabolismoRESUMEN
Hepatitis C virus (HCV) infection is a significant world health threat with frequently ineffective problem existed in the present treatment, thus representing a major unmet medical need. The nonstructural viral protein 5B (NS5B), one of the best-studied polymerase, has emerged as an attractive target for the development of novel therapeutics against hepatitis C virus. In this work, both ligand- and receptor- based three-dimensional quantitative structure activity relationship (3D-QSAR) studies were carried out using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques on 360 benzothiadiazine scaffold-based derivatives as HCV GT-1b NS5B polymerase allosteric inhibitors. The resultant optimum 3D-QSAR model exhibited R(2)(ev) of 0.54, R(2)(nev) of 0.72 and the predictive ability was validated by using an independent test set of 90 compounds which gave R(2)(pred) value of 0.64. In addition, docking analysis and molecular dynamics simulation (MD) were also applied to elucidate the probable binding modes of these inhibitors at the allosteric site of the enzyme. Interpretation of the 3D contour maps in context of the topology of the allosteric binding site of NS5B provided insight into NS5B-inhibitor interactions. The information obtained from this work can be utilized to accurately predict the binding affinity of related analogues and also facilitate the future rational design of novel inhibitors with improved activity.
Asunto(s)
Benzotiadiazinas/farmacología , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Hepacivirus/química , Hepacivirus/enzimología , Hepatitis C/tratamiento farmacológico , Proteínas no Estructurales Virales/antagonistas & inhibidores , Animales , Benzotiadiazinas/química , Benzotiadiazinas/metabolismo , Benzotiadiazinas/uso terapéutico , Sitios de Unión , Diseño de Fármacos , Descubrimiento de Drogas , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/uso terapéutico , Hepacivirus/genética , Hepacivirus/metabolismo , Hepatitis C/epidemiología , Hepatitis C/genética , Humanos , Concentración 50 Inhibidora , Modelos Moleculares , Simulación de Dinámica Molecular , Terapia Molecular Dirigida , Unión Proteica , Relación Estructura-Actividad Cuantitativa , Bibliotecas de Moléculas Pequeñas , Proteínas no Estructurales Virales/química , Proteínas no Estructurales Virales/metabolismoRESUMEN
Hypothalamic hypocretin/orexin (hcrt/orx) neurons promote arousal and reward seeking, while reduction in their activity has been linked to narcolepsy, obesity and depression. However, the mechanisms influencing the activity of hcrt/orx networks in situ are not fully understood. Here we show that glycine, a neurotransmitter best known for its actions in the brainstem and spinal cord, elicits dose dependent postsynaptic Clâ» currents in hcrt/orx cells in acute mouse brain slices. The effect was blocked by the glycine receptor (GLyR) antagonist strychnine and mimicked by the GlyR agonist alanine. Postsynaptic GlyRs on hcrt/orx cells remained functional during both early postnatal and adult periods, and gramicidin-perforated patch-clamp recordings revealed that they progressively switch from excitatory to inhibitory during the first two postnatal weeks. The pharmacological profile of the glycine response suggested that developed hcrt/orx neurons contain α/ß-heteromeric GlyRs that lack α2-subunits, whereas α2-subunits, whereas α2-subunits are present in early postnatal hcrt/orx neurons. All postsynaptic currents (PSCs) in developed hcrt/orx cells were blocked by inhibitors of GABA and glutamate receptors, with no evidence of GlyR-mediated PSCs. However, the frequency but not amplitude of miniature PSCs was reduced by strychnine and increased by glycine in ~50% of hcrt/orx neurons. Together, these results provide the first evidence for functional GlyRs in identified hcrt/orx circuits and suggest that the activity of developed hcrt/orx cells is regulated by two GlyR pools: inhibitory extrasynaptic GlyRs located on all hcrt/orx cells and excitatory GlyRs located on presynaptic terminals contacting some hcrt/orx cells.
Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/metabolismo , Neuronas/fisiología , Neuropéptidos/metabolismo , Receptores de Glicina/fisiología , 6-Ciano 7-nitroquinoxalina 2,3-diona/farmacología , Envejecimiento/fisiología , Alanina/farmacología , Animales , Animales Recién Nacidos , Benzotiadiazinas/farmacología , Canales de Cloruro/fisiología , Fenómenos Electrofisiológicos/efectos de los fármacos , Fenómenos Electrofisiológicos/fisiología , Antagonistas del GABA/farmacología , Ácido Glutámico/metabolismo , Glicina/farmacología , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/crecimiento & desarrollo , Hipotálamo/fisiología , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Ratones , Ratones Transgénicos , Neuronas/efectos de los fármacos , Orexinas , Técnicas de Placa-Clamp , Picrotoxina/farmacología , Piridazinas/farmacología , Receptores de GABA/fisiología , Receptores de Glutamato/fisiología , Receptores de Glicina/antagonistas & inhibidores , Estricnina/farmacología , Potenciales Sinápticos/efectos de los fármacos , Potenciales Sinápticos/fisiología , Ácido gamma-Aminobutírico/metabolismoRESUMEN
This study examined Wiking-cultivar table potato tubers in a field experiment conducted between 2002 and 2004 using a rye complex soil. The experimental factors included (a) two methods of tillage, including traditional and simplified, as well as (b) seven methods of cultivation with the use of herbicides as follows: 1, control without herbicides; 2, Plateen 41.5 WG; 3, Plateen 41.5 WG + Fusilade Forte 150 EC; 4, Plateen 41.5 WG + Fusilade Forte 150 EC + adjuvant Atpolan 80 EC; 5, Barox 460 SL; 6, Barox 460 SL + Fusilade Forte 150 EC; and 7, Barox 460 SL + Fusilade Forte 150 EC + adjuvant Atpolan 80 EC. Determination of residues was performed using high-performance liquid and gas chromatography. Only trace quantities of bentazone (Barox 460 SL) were found in potato tubers, amounts that fell below the maximum residue limit (MRL). The nitrate content of potato tubers was determined using a nitrate ion-selective electrode and silver chloride reference electrode. The nitrate content in fresh matter of unpeeled and peeled tubers depended significantly only on weather conditions in the years of study. In contrast, agrotechnical procedures such as methods of tillage and cultivation did not significantly affect potato tuber nitrate content.
Asunto(s)
Herbicidas/análisis , Solanum tuberosum/química , Benzotiadiazinas , Cromatografía de Gases , Electrodos de Iones Selectos , Nitratos/análisis , Suelo/análisis , Tiempo (Meteorología)RESUMEN
In an effort to discover new and effective chemotherapeutic agents from this laboratory for the treatment of tuberculosis, here in we describe the synthesis and biological evaluation of a series of novel benzothiadiazine 1,1-dioxide (BTD) based congeners by using rifampicin, streptomycin; ciprofloxacin and amphotericin as positive controls. Further, to understand structural requirements for exploring the structure activity relationship of BTDs, cytotoxicity and in vivo study of recently reported potent molecule 4 (MIC = 1 microg/mL) is also discussed.
Asunto(s)
Antituberculosos/química , Antituberculosos/uso terapéutico , Benzotiadiazinas/química , Benzotiadiazinas/uso terapéutico , Mycobacterium tuberculosis/efectos de los fármacos , Tuberculosis/tratamiento farmacológico , Animales , Antituberculosos/síntesis química , Antituberculosos/farmacología , Bacterias/efectos de los fármacos , Benzotiadiazinas/síntesis química , Benzotiadiazinas/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Femenino , Hongos/efectos de los fármacos , Humanos , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad MicrobianaRESUMEN
The synthesis of 5-chloro-, 6-chloro-, and 8-chloro-substituted 3-alkylamino/cycloalkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides is described. Their inhibitory effect on the insulin releasing process and their vasorelaxant activity was compared to that of previously reported 7-chloro-3-alkylamino/cycloalkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides. "5-Chloro" compounds were found to be essentially inactive on both the insulin-secreting and the smooth muscle cells. By contrast, "8-chloro" and "6-chloro" compounds were found to be active on insulin-secreting cells, with the "6-chloro" derivatives emerging as the most potent drugs. Moreover, the "6-chloro" analogues exhibited less myorelaxant activity than their "7-chloro" counterparts. 8-Chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (25b) and 6-chloro-3-cyclobutylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (19e) were further identified as K(ATP) channel openers by radioisotopic measurements conducted on insulin-secreting cells. Likewise, current recordings on HEK293 cells expressing human SUR1/Kir6.2 channels confirmed the highly potent activity of 19e (EC(50) = 80 nM) on such types of K(ATP) channels. The present work indicates that 6-chloro-3-alkylamino/cycloalkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides appear to be more attractive than their previously described 7-chloro-substituted analogues as original drugs activating the SUR1/Kir6.2 K(ATP) channels.
Asunto(s)
Benzotiadiazinas/farmacología , Cloro/química , Óxidos S-Cíclicos/farmacología , Diazóxido/análogos & derivados , Diazóxido/farmacología , Islotes Pancreáticos/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Canales de Potasio/efectos de los fármacos , Adenosina Trifosfato/metabolismo , Animales , Benzotiadiazinas/síntesis química , Benzotiadiazinas/química , Línea Celular , Óxidos S-Cíclicos/síntesis química , Óxidos S-Cíclicos/química , Diazóxido/química , Evaluación Preclínica de Medicamentos , Glucosa/farmacología , Humanos , Insulina/metabolismo , Secreción de Insulina , Islotes Pancreáticos/metabolismo , Estructura Molecular , Músculo Liso Vascular/metabolismo , Canales de Potasio/metabolismo , Ratas , EstereoisomerismoRESUMEN
Substituted N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides were investigated as inhibitors of genotype 1 HCV polymerase. Structure-activity relationship patterns for this class of compounds are discussed.
Asunto(s)
Benzotiadiazinas , Inhibidores Enzimáticos , Sulfonamidas , Proteínas no Estructurales Virales/antagonistas & inhibidores , Benzotiadiazinas/síntesis química , Benzotiadiazinas/química , Benzotiadiazinas/farmacología , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Estructura Molecular , Relación Estructura-Actividad , Sulfonamidas/síntesis química , Sulfonamidas/química , Sulfonamidas/farmacología , Proteínas no Estructurales Virales/químicaRESUMEN
Synaptic depression produced by repetitive stimulation is likely to be particularly important in shaping responses of second-order retinal neurons at the tonically active photoreceptor synapse. We analyzed the time course and mechanisms of synaptic depression at rod and cone synapses using paired-pulse protocols involving two complementary measurements of exocytosis: (1) paired whole-cell recordings of the postsynaptic current (PSC) in second-order retinal neurons and (2) capacitance measurements of vesicular membrane fusion in rods and cones. PSCs in ON bipolar, OFF bipolar, and horizontal cells evoked by stimulation of either rods or cones recovered from paired-pulse depression (PPD) at rates similar to the recovery of exocytotic capacitance changes in rods and cones. Correlation between presynaptic and postsynaptic measures of recovery from PPD suggests that 80-90% of the depression at these synapses is presynaptic in origin. Consistent with a predominantly presynaptic mechanism, inhibiting desensitization of postsynaptic glutamate receptors had little effect on PPD. The depression of exocytotic capacitance changes exceeded depression of the presynaptic calcium current, suggesting that it is primarily caused by a depletion of synaptic vesicles. In support of this idea, limiting Ca2+ influx by using weaker depolarizing stimuli promoted faster recovery from PPD. Although cones exhibit much faster exocytotic kinetics than rods, exocytotic capacitance changes recovered from PPD at similar rates in both cell types. Thus, depression of release is not likely to contribute to differences in the kinetics of transmission from rods and cones.
Asunto(s)
Estimulación Eléctrica , Inhibición Neural/efectos de la radiación , Células Fotorreceptoras/fisiología , Sinapsis/fisiología , Animales , Benzotiadiazinas/farmacología , Relación Dosis-Respuesta en la Radiación , Capacidad Eléctrica , Exocitosis/efectos de los fármacos , Exocitosis/fisiología , Glutamatos/farmacología , Técnicas In Vitro , Indoles/farmacología , Técnicas de Placa-Clamp/métodos , Células Fotorreceptoras/efectos de la radiación , Terminales Presinápticos/efectos de los fármacos , Terminales Presinápticos/fisiología , Terminales Presinápticos/efectos de la radiación , Células Fotorreceptoras Retinianas Conos/fisiología , Células Fotorreceptoras Retinianas Conos/efectos de la radiación , Células Fotorreceptoras Retinianas Bastones/fisiología , Células Fotorreceptoras Retinianas Bastones/efectos de la radiación , Sinapsis/efectos de la radiación , Factores de Tiempo , Urodelos , Vías Visuales/fisiología , Vías Visuales/efectos de la radiaciónRESUMEN
We have constructed stable HEK293 cell lines expressing the rat ionotropic glutamate receptor subtypes GluR1(i), GluR2Q(i), GluR3(i), GluR4(i), GluR5Q and GluR6Q and characterised the pharmacological profiles of the six homomeric receptors in a fluorescence-based high throughput screening assay using Fluo-4/AM as a fluorescent Ca2+ indicator. In this assay, the pharmacological properties of nine standard GluR ligands correlated nicely with those previously observed in electrophysiology studies of GluRs expressed in Xenopus oocytes or mammalian cells. The potencies and efficacies displayed by the agonists (S)-glutamate, (S)-quisqualate, kainate, (RS)-AMPA, (RS)-ATPA, (RS)-ACPA] and (S)-4-AHCP at the six GluRs were in concordance with electrophysiological studies. Furthermore, the Ki values exhibited by the competitive antagonists NBQX and (RS)-ATPO were also in agreement with findings of previous studies. Finally, the effects of various concentrations of Ca2+ in the assay buffer and of the allosteric modulators cyclothiazide and concanavalin A on GluR signalling were examined. This study represents the most elaborate functional characterisation of multiple AMPA and KA receptor subtypes in the same assay reported to date. We propose that high throughput screening of compound libraries at the six GluR-HEK293 cell lines could be helpful in the search for structurally and pharmacologically novel ligands acting at the receptors.
Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Receptores de Glutamato/efectos de los fármacos , Compuestos de Anilina/análisis , Compuestos de Anilina/metabolismo , Benzotiadiazinas/farmacología , Calcio/metabolismo , Calcio/farmacología , Línea Celular , Técnicas Químicas Combinatorias , Concanavalina A/farmacología , Electrofisiología , Agonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Fluorescencia , Ácido Glutámico/farmacología , Humanos , Ácido Kaínico/farmacología , Quinoxalinas/farmacología , Receptores AMPA/efectos de los fármacos , Receptores AMPA/genética , Receptores AMPA/metabolismo , Receptores de Glutamato/genética , Receptores de Glutamato/metabolismo , Transducción de Señal , Xantenos/análisis , Xantenos/metabolismoRESUMEN
A series of N-1,3 disubstituted 2,1,3-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoform PDE4 extracted from U937 cell line. Some of the tested compounds showed a high PDE4 inhibitory activity at 100 microM and the IC(50) value of the most interesting terms were evaluated. The structure-activity relationships of these compounds showed that the 3,5-di-tert-butyl-4-hydroxybenzyl moiety at N-1 position is important to obtain activity at micromolar level as previously reported. For the same compounds the antioxidant activity were evaluated highlighting 14 as the most significative one. The introduction of other bulky substituents in N-1 position is detrimental.
Asunto(s)
3',5'-AMP Cíclico Fosfodiesterasas/antagonistas & inhibidores , Benzotiadiazinas/síntesis química , Benzotiadiazinas/farmacología , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Benzotiadiazinas/química , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/química , Humanos , Isoenzimas/antagonistas & inhibidores , Estructura Molecular , Relación Estructura-Actividad , Células U937RESUMEN
Over 59 generations, a strain of rats has been inbred to maximize urine calcium excretion. The rats now excrete eight to 10 times as much calcium as controls. These rats uniformly form calcium phosphate (apatite) kidney stones and have been termed genetic hypercalciuric stone-forming (GHS) rats. The addition of a common amino acid and oxalate precursor, hydroxyproline, to the diet of the GHS rats leads to formation of calcium oxalate (CaOx) kidney stones. Hydroxyproline-supplemented GHS rats were used to test the hypothesis that the thiazide diuretic chlorthalidone would decrease urine calcium excretion, supersaturation, and perhaps stone formation. All GHS rats received a fixed amount of a standard 1.2% calcium diet with 5% trans-4-hydroxy-l-proline (hydroxyproline) so that the rats would exclusively form CaOx stones. Half of the rats had chlorthalidone (Thz; 4 to 5 mg/kg per d) added to their diets. Urine was collected weekly, and at the conclusion of the study, the kidneys, ureters, and bladders were radiographed for the presence of stones. Compared with control, the addition of Thz led to a significant reduction of urine calcium and phosphorus excretion, whereas urine oxalate excretion increased. Supersaturation with respect to the calcium hydrogen phosphate fell, whereas supersaturation with respect to CaOx was unchanged. Rats that were fed Thz had fewer stones. As calcium phosphate seems to be the preferred initial solid phase in patients with CaOx kidney stones, the reduction in supersaturation with respect to the calcium phosphate solid phase may be the mechanism by which thiazides reduce CaOx stone formation.
Asunto(s)
Benzotiadiazinas , Calcinosis/tratamiento farmacológico , Oxalato de Calcio/orina , Fosfatos de Calcio/orina , Cálculos Renales/química , Inhibidores de los Simportadores del Cloruro de Sodio/farmacología , Animales , Calcinosis/genética , Oxalato de Calcio/química , Fosfatos de Calcio/química , Modelos Animales de Enfermedad , Diuréticos , Hipercalcemia/diagnóstico , Hipercalcemia/tratamiento farmacológico , Cálculos Renales/orina , Modelos Lineales , Masculino , Probabilidad , Ratas , Ratas Endogámicas , Valores de Referencia , Sensibilidad y Especificidad , UrinálisisRESUMEN
Earlier studies showed that positive modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors enhance synaptic responses and facilitate synaptic plasticity. Those studies focused mainly on hippocampal functions. However, AMPA receptors have regionally distinct subunit compositions and thus potencies and efficacies of modulators may vary across the brain. The present study compared the effects of CX546 [1-(1,4-benzodioxan-6-ylcarbonyl) piperidine], a benzamide-type modulator, on synaptic transmission in neurons of the reticular thalamic nucleus (RTN), which regulates the firing mode of relay cells in other thalamic nuclei, and on hippocampal CA1 pyramidal cells. CX546 greatly prolonged synaptic responses in CA1 pyramidal cells, but at the same concentration it had only weak modulatory effects in RTN neurons. Effects on miniature excitatory postsynaptic currents (EPSCs) were similar to those on EPSCs in both regions, suggesting that variations in neuronal morphology and transmitter release kinetics do not account for the differences. Relay cells in the ventrobasal thalamus also exhibited weak modulatory effects that were comparable with those in RTN neurons. Regionally different effects on response duration were also observed with CX516 [BDP-12, 1-(quinoxalin-6-ylcarbonyl)piperidine], a second benzamide drug. In contrast, 100 microM cyclothiazide produced comparable synaptic enhancements in hippocampus and RTN. The regional selectivity of benzamide drugs (ampakines) may be explained, at least in part, by a lower potency at thalamic AMPA receptors, perhaps due to the prevalence of the subunits GluR3 and 4. Although regional preferences of the ampakines were modest in their extent, they may be sufficient to be of relevance when considering future therapeutic applications of such compounds.
Asunto(s)
Hipocampo/efectos de los fármacos , Receptores AMPA/agonistas , Transmisión Sináptica/efectos de los fármacos , Tálamo/efectos de los fármacos , Animales , Benzotiadiazinas/farmacología , Dioxoles/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Técnicas In Vitro , Masculino , Potenciales de la Membrana/efectos de los fármacos , Técnicas de Placa-Clamp , Piperidinas/farmacología , Ratas , Ratas Sprague-DawleyRESUMEN
A case-control study of 1,150 female and male distal forearm cases and 2,331 controls of age 45 years and older was undertaken from 1996-2001 in five Northern California Kaiser Permanente Medical Centers. Most information on possible risk factors was obtained by an interviewer-administered questionnaire, supplemented by a few tests of lower extremity neurological function. Previous fractures since 45 years of age, a rough marker of osteoporosis, were associated with an increased risk (adjusted odds ratio [OR] [95% confidence interval] = 1.48 [1.20-1.84 ] per previous fracture). Several factors thought to protect against low bone mass were associated with a reduced risk, including current use of menopausal hormone therapy (adjusted OR = 0.60 [0.49-0.74]), ever used thiazide diuretics or water pills for at least 1 year (adjusted OR = 0.79 [0.64-0.97]), high body mass index (weight in kg/height in m2) (adjusted OR = 0.96 [0.89-1.04] per 5 unit increase), and high dietary calcium intake (adjusted OR = 0.88 [0.75-1.03] per 500 mg/day). Falls in the past year and conditions associated with falling, such as epilepsy and/or use of seizure medication (adjusted OR = 2.07 [1.35-3.17]) and a history of practitioner-diagnosed depression (adjusted OR = 1.40 [1.13-1.73]), were associated with increased risks. Having difficulty performing physical functions and all lower-extremity problems measured in this study were associated with reduced risks. The results from this and other studies indicate that distal forearm fractures tend to occur in people with low bone mass who are otherwise in relatively good health and are physically active, but who are somewhat prone to falling (particularly on an outstretched hand), and whose movements are not slowed by lower extremity problems and other debilities. Thus, measures to decrease fall frequency and to slow down the pace of relatively healthy people with low bone mass should lead to a lower frequency of distal forearm fracture.
Asunto(s)
Traumatismos del Antebrazo/prevención & control , Fracturas Óseas/prevención & control , Prevención de Accidentes , Accidentes por Caídas/prevención & control , Anciano , Benzotiadiazinas , Índice de Masa Corporal , Densidad Ósea , Calcio de la Dieta/administración & dosificación , Estudios de Casos y Controles , Diuréticos , Terapia de Reemplazo de Estrógeno , Femenino , Traumatismos del Antebrazo/etiología , Traumatismos del Antebrazo/fisiopatología , Fracturas Óseas/etiología , Fracturas Óseas/fisiopatología , Humanos , Estilo de Vida , Masculino , Persona de Mediana Edad , Osteoporosis/complicaciones , Osteoporosis/prevención & control , Fracturas del Radio/fisiopatología , Fracturas del Radio/prevención & control , Recurrencia , Factores de Riesgo , Conducta de Reducción del Riesgo , Inhibidores de los Simportadores del Cloruro de Sodio/uso terapéutico , Fracturas del Cúbito/fisiopatología , Fracturas del Cúbito/prevención & controlRESUMEN
Neither severe distal renal tubular acidosis nor hypercalciuria have been recognized to cause severe hypocalcaemia. We describe a 53 years old woman with distal renal tubular acidosis and hypercalciuria who demonstrated severe hypocalcemia, normalized after calcium and vitamin D supplementation and treatment with thiazide.
Asunto(s)
Acidosis Tubular Renal/complicaciones , Acidosis Tubular Renal/tratamiento farmacológico , Compuestos de Calcio/orina , Hipocalcemia/tratamiento farmacológico , Hipocalcemia/etiología , Acidosis Tubular Renal/orina , Antihipertensivos/administración & dosificación , Benzotiadiazinas , Calcio de la Dieta/administración & dosificación , Diagnóstico Diferencial , Diuréticos , Femenino , Humanos , Hiperparatiroidismo/etiología , Hipocalcemia/orina , Persona de Mediana Edad , Inhibidores de los Simportadores del Cloruro de Sodio/administración & dosificación , Factores de Tiempo , Resultado del Tratamiento , Vitamina D/administración & dosificaciónRESUMEN
BACKGROUND: Calcium antagonists retard progression of intima-media thickness (IMT), but whether this retardation covers heterogeneous individual patient responses of IMT change is unknown. METHODS: Hypertensive patients treated for 4 years with nifedipine (n = 115) or coamilozide (n = 127) underwent ultrasound measurements of carotid IMT at baseline, 4 months later, and then every year. RESULTS: A histogram of individual slopes of IMT change (least square regression of IMT to time) during treatment identified three categories of slopes according to the 20th and 80th percentiles of distribution: lower, intermediate and higher percentiles of IMT slope; the proportion of categories of IMT slope differed between treatments (P < 0.05), due to a more frequent lower slope percentile under nifedipine (27%) than under coamilozide (14%); within-group differences between IMT slope categories were: (i) increased baseline IMT associated with lower IMT slope percentile in nifedipine group (P < 0.001) and (ii) more frequent carotid plaque associated with higher IMT slope percentile in both treatment groups (P < 0.05). Analysis of overall patients showed that IMT slope was associated negatively with nifedipine treatment (P < 0.01) and baseline IMT (P < 0.001) and positively with carotid plaque (P < 0.01); the relationship between IMT slope and baseline IMT was negative under nifedipine and flat under coamilozide, and the presence of plaque reset both relationships towards a higher IMT slope; the between-treatment difference in IMT slope was different between tertiles of baseline IMT (P = 0.016). CONCLUSIONS: The differences in IMT slope between nifedipine and coamilozide increase with increasing baseline IMT.